36IQ
Structure of de novo designed doxorubicin binding protein with doxorubicin bound
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 8.3.1 |
| Synchrotron site | ALS |
| Beamline | 8.3.1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2026-03-10 |
| Detector | DECTRIS PILATUS3 S 6M |
| Wavelength(s) | 1.11582 |
| Spacegroup name | P 32 2 1 |
| Unit cell lengths | 42.700, 42.700, 174.710 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 58.240 - 1.560 |
| R-factor | 0.2211 |
| Rwork | 0.218 |
| R-free | 0.25520 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.010 |
| RMSD bond angle | 0.994 |
| Data reduction software | XDS |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | PHENIX (2.0_5848) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 87.350 | 1.590 |
| High resolution limit [Å] | 1.560 | 1.560 |
| Rmerge | 0.177 | 1.557 |
| Rmeas | 0.182 | 1.609 |
| Number of reflections | 27441 | 1348 |
| <I/σ(I)> | 19 | 3.8 |
| Completeness [%] | 99.7 | |
| Redundancy | 35.3 | 30.6 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 293 | 500 mM HEPES, 489 mM Sodium Citrate,68.5 mM Sodium Chloride, 5 mM Sodium phosphate dibasic, 0.9 mM Potassium phosphate monobasic, 1.35 mM Potassium chloride, pH 7.25 |






